Citation Impact
Citing Papers
Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH
2011
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement
2013
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Guidelines for radioiodine therapy of differentiated thyroid cancer
2008
Italian consensus for the classification and reporting of thyroid cytology
2014 Standout
The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview
2012
Health‐related quality of life among thyroid cancer survivors: a systematic review
2011
Thyroid cancer
2016 Standout
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study
2001
Identification of occult metastases of medullary thyroid carcinoma by pentagastrin‐stimulated intravenous calcitonin sampling followed by targeted surgery
2007
Dosimetry of 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes
2018
Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer
2011
Does positron emission tomography data acquisition impact simultaneous diffusion-weighted imaging in a whole-body PET/MRI system?
2012
Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
2008 Standout
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
2004
Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
2011
Role of isotope scan, including positron emission tomography/computed tomography, in nodular goitre
2014
Phaeochromocytoma
2005 Standout
Head and neck cancer
2008 Standout
Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET
2005
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
131I SPECT/CT in the Follow-up of Differentiated Thyroid Carcinoma: Incremental Value Versus Planar Imaging
2009
Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care
2013
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma
2007
Potential Use of Recombinant Human Thyrotropin in the Treatment of Distant Metastases in Patients with Differentiated Thyroid Cancer
2012
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis
2009
The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
2012 Standout
Utilidad de la 18F-FDG PET/TC en el cáncer de tiroides
2016
Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study
2013
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
Das medulläre Schilddrüsenkarzinom
2015
European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS
2017 Standout
SPECT/CT imaging in children with papillary thyroid carcinoma
2011
Dosimetry and thyroid cancer: the individual dosage of radioiodine
2010
Associations between benefit finding and adjustment outcomes in thyroid cancer
2011
Persistent Posttreatment Fatigue in Thyroid Cancer Survivors
2014
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
2013 Standout
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee
2017 Standout
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
2009
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Psychological Well-Being Revisited: Advances in the Science and Practice of Eudaimonia
2013 Standout
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
2012
The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials
2008
Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors
2012
Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels
2007
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0
2012
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
2008
Psychological impact of thyroid surgery on patients with well-differentiated papillary thyroid cancer
2011
124I PET-Based 3D-RD Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic Comparison
2009
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma
2012
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma
2012
Positron emission imaging of head and neck cancer, including thyroid carcinoma
2004
Autonomous Structural Visual Inspection Using Region‐Based Deep Learning for Detecting Multiple Damage Types
2017 Standout
Lack of Elevated Serum Carcinoembryonic Antigen and Calcitonin in Medullary Thyroid Carcinoma
2004
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
The 2017 Bethesda System for Reporting Thyroid Cytopathology
2017 Standout
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Quality of Life in Patients with Thyroid Cancer Compared with the General Population
2011
A Systematic Review of Randomized Controlled Trials for Management of Persistent Post-Treatment Fatigue in Thyroid Cancer Survivors
2014
Imaging and machine learning techniques for diagnosis of Alzheimer’s disease
2016
Diagnosing Alzheimer's disease in elderly, mildly demented patients: the impact of routine single photon emission computed tomography
1995
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy
2007
Complications of Radioactive Iodine Treatment of Thyroid Carcinoma
2010
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
2013 Standout
Quality of Life and Anxiety in Adolescents with Differentiated Thyroid Cancer
2012
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma
2004
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
2004
Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome
2012
Cancer treatment and survivorship statistics, 2019
2019 Standout
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
2021 Standout
Approach to the Patient: Role of Dosimetric RAI Rx in Children With DTC
2013
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma.
2002
Guidelines for the management of thyroid cancer
2014 Standout
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
The Treatment of Differentiated Thyroid Cancer in Children: Emphasis on Surgical Approach and Radioactive Iodine Therapy
2011
PET/CT Imaging of Thyroid Cancer
2011
The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I
2009
Works of Andreas Bockisch being referenced
18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy
2012
Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid Carcinoma
2012
Relationship between cumulative radiation dose and salivary gland uptake associated with radioiodine therapy of thyroid cancer
2006
Virtual 3-D 18F-FDG PET/CT panendoscopy for assessment of the upper airways of head and neck cancer patients: a feasibility study
2012
Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer
2007
Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer
2011
Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment
2005
PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status
2015
The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging
2010
Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisons
2010
Diagnosis and dosimetry in differentiated thyroid carcinoma using 124I PET: comparison of PET/MRI vs PET/CT of the neck
2011
Effects of Rosiglitazone on Radioiodine Negative and Progressive Differentiated Thyroid Carcinoma as Assessed by 124I PET/CT Imaging
2012
Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer
2008
Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET Imaging
2014
Protektive Faktoren für Angst und Depression bei Schilddrüsenkarzinompatienten
2007
Euthyroid Goiter With and Without Nodules
2012
Radionuclide-Labeled Somatostatin Analogues for Diagnostic and Therapeutic Purposes in Nonmedullary Thyroid Cancer
2001
68Ga-DOTATOC PET/CT and somatostatin receptor (sst1–sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax
2011
Disseminated iodine-avid lung metastases in differentiated thyroid cancer: a challenge to 124I PET
2007
The value of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with medullary thyroid cancer
2000
Health-related Quality of Life, Depression and Anxiety in Thyroid Cancer Patients
2006
Segmentation of PET volumes by iterative image thresholding.
2007
Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen.
2007
Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures.
2005
HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS).
1990
Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging.
2003
Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans.
2002